A prevalence study of urinary tract infections in acute relapse of schizophrenia

Journal of Clinical Psychiatry

Volumn 74, Issue 3, 2013, Pages 271-277

  Miller, Brian J ^a   Graham, Krystle L ^a   Bodenheimer, Chelsea M ^a   Culpepper, Nick H ^a   Waller, Jennifer L ^a   Buckley, Peter F ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; URINARY TRACT INFECTION;

EID: 84875480380     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m08050     Document Type: Article

References (31)

1. Brown S, Kim M, Mitchell C, et al. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry. 2010;196(2):116-121.
2. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123-1131. (Pubitemid 47529346)
3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(suppl 1a):S5-S13.
4. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996. Vital Health Stat 13. 1998;134:1-37.
5. Juthani-Mehta M, Quagliarello V, Perrelli E, et al. Clinical features to identify urinary tract infection in nursing home residents: a cohort study. J Am Geriatr Soc. 2009;57(6):963-970.
6. Manepalli J, Grossberg GT, Mueller C. Prevalence of delirium and urinary tract infection in a psychogeriatric unit. J Geriatr Psychiatry Neurol. 1990;3(4):198-202.
7. Woo BK, Daly JW, Allen EC, et al. Unrecognized medical disorders in older psychiatric inpatients in a senior behavioral health unit in a university hospital. J Geriatr Psychiatry Neurol. 2003;16(2):121-125. (Pubitemid 37409042)
8. Berber MJ, McFeely N. Efficacy of routine admission urinalyses in psychiatric hospitals. Can J Psychiatry. 1991;36(3):190-193.
9. Robinson D, Woerner MG, Alvir JM, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56(3):241-247. (Pubitemid 29125132)
10. Müller N, Riedel M, Scheppach C, et al. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry. 2002;159(6):1029-1034. (Pubitemid 34586950)
11. Shepherd M, Watt D, Falloon I, et al. The Natural History of Schizophrenia: A Five-Year Follow-Up Study of Outcome and Prediction in a Representative Sample of Schizophrenics. Psychol Med Monogr Suppl. 1989;15:1-46. (Pubitemid 19234086)
12. Wyatt RJ. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophr Res. 1991;5(3):201-202.
13. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010;167(3):261-280.
14. Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663-671.
15. Miller BJ, Culpepper N, Rapaport MH. C-reactive protein in schizophrenia: a review and meta-analysis. Clin Schizophr Rel Psychoses. In press.
16. McAdams C, Leonard BE. Neutrophil and monocyte phagocytosis in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17(6):971-984. (Pubitemid 23330690)
17. DeRenzo EG, Conley RR, Love R. Assessment of capacity to give consent to research participation: state-of-the-art and beyond. J Health Care Law Policy. 1998;1(1):66-87.
18. Ford P. An evaluation of the Dartmouth Assessment of Lifestyle Inventory and the Leeds Dependence Questionnaire for use among detained psychiatric inpatients. Addiction. 2003;98(1):111-118. (Pubitemid 36044343)
19. Fennig S, Craig T, Lavelle J, et al. Best-estimate versus structured interviewbased diagnosis in first-admission psychosis. Compr Psychiatry. 1994;35(5):341-348. (Pubitemid 24288516)
20. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004;38(8):1150-1158. (Pubitemid 38951264)
21. Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am. 1991;75(2):313-325.
22. Ulmar G, Schunck H, Kober C. Urinary retention in the course of neuroleptic therapy with haloperidol. Pharmacopsychiatry. 1988;21(4):208-209.
23. Lipowski ZJ. Delirium due to infection. In: Lipowski ZJ, ed. Delirium: Acute Brain Failure in Man. Springfield, IL: Charles C Thomas; 1980:409-425.
24. Huber J, Huber CG, Lambert M, et al. 'Stoned': Schneiderian first-rank symptoms as a manifestation of bilateral obstructive urolithiasis [letter]. Br J Psychiatry. 2010;196(6):496-497.doi:10.192/bjp.196.6.496
25. Rajagopalan M, Varma SL. Urinary tract infection and delusion of pregnancy. Aust N Z J Psychiatry. 1997;31(5):775-776. (Pubitemid 27480600)
26. Reeves RR. Exacerbation of psychotic symptoms associated with gatifloxacin [letter]. Psychosomatics. 2007;48(1):87. (Pubitemid 46048034)
27. Tomé AM, Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf. 2011;34(6):465-488.
28. Schlotz W, Phillips DI. Fetal origins of mental health: evidence and mechanisms. Brain Behav Immun. 2009;23(7):905-916.
29. Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci. 2009;3:14.
30. Rwegellera GG, Fernando KA, Okong'o O. Bactericidal activity of neutrophils of schizophrenic patients. Med J Zambia. 1982;16(2):21-22.
31. Abdeljaber MH, Nair MP, Schork MA, et al. Depressed natural killer cell activity in schizophrenic patients. Immunol Invest. 1994;23(4-5):259-268. (Pubitemid 24250861)